NCT04710264View on ClinicalTrials.gov

Aurora Test for Patients Treated With Recombinant Gonadotropins

CompletedOBSERVATIONAL
Enrollment

137

Participants

Timeline

Start Date

February 15, 2021

Primary Completion Date

December 31, 2023

Study Completion Date

September 1, 2025

Conditions
Infertility
Interventions
OTHER

AURORA-Rec

Explorative study of cumulus cells gene expression in relation to the patient treatment and oocyte competence.

Trial Locations (1)

1090

Universitair Ziekenhuis Brussel, Jette

All Listed Sponsors
collaborator

Merck Healthcare KGaA, Darmstadt, Germany, an affiliate of Merck KGaA, Darmstadt, Germany

INDUSTRY

lead

Fertiga, Belgium

INDUSTRY

NCT04710264 - Aurora Test for Patients Treated With Recombinant Gonadotropins | Biotech Hunter | Biotech Hunter